InsiderClue
Insiders · Profile

PFIZER INC

10% owner at Pyxis Oncology · 10% owner at Quince Therapeutics · 10% owner at Enliven Therapeutics · and 5 more. Filing since 6 Feb 2013. CIK 0000078003

PYXS Pyxis Oncology, Inc. 10% owner · 1 trade QNCX Quince Therapeutics, Inc. 10% owner · 2 trades ELVN Enliven Therapeutics, Inc. 10% owner · 1 trade ICUI ICU MEDICAL INC/DE Director · 2 trades ALLO Allogene Therapeutics, Inc. 10% owner · 1 trade RYTM RHYTHM PHARMACEUTICALS, INC. 10% owner · 1 trade NGNE Neurogene Inc. 10% owner · 2 trades ZTS Zoetis Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
PYXS Pyxis Oncology, Inc.
17 Mar 2023
10% owner
Bought
1,811,594
$5.00M
43.8%
QNCX Quince Therapeutics, Inc.
3 Jun 2020
10% owner
Sold, plan not stated
370,000
$14.87M
11.4%
ELVN Enliven Therapeutics, Inc.
16 Mar 2020
10% owner
Bought
312,500
$5.00M
26.7%
QNCX Quince Therapeutics, Inc.
13 May 2019
10% owner
Bought
50,000
$850.00K
1.6%
ICUI ICU MEDICAL INC/DE
15 Nov 2018
Director
Sold, plan not stated
2,500,000
$523.13M
100%
ALLO Allogene Therapeutics, Inc.
15 Oct 2018
10% owner
Bought
55,556
$1.00M
0.3%
ICUI ICU MEDICAL INC/DE
13 Aug 2018
Director
Sold, plan not stated
700,000
$199.05M
21.9%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
10% owner
Bought
40,000
$680.00K
2.9%
NGNE Neurogene Inc.
10 Aug 2015
10% owner
Sold, plan not stated
259,927
$6.88M
21.0%
NGNE Neurogene Inc.
12 Mar 2014
10% owner
Bought
272,727
$3.00M
28.3%
ZTS Zoetis
6 Feb 2013
Director
Sold, plan not stated
99,015,000
no price
100%
11 decisions on file.